Johnson & Johnson Highlights Strong Sales Growth and Future Acquisitions
Tuesday, 16 April 2024, 17:30
Johnson & Johnson's Strong Q1 2024 Earnings Performance
Sales Growth Highlights:
- Key growth in sectors like Innovative Medicine and MedTech
- Global strength in Cardiovascular and Electrophysiology (EP) with over 20% growth
Acquisition Plans and Future Outlook
Acquisition Announcement:
- Planned acquisition of Shockwave to strengthen leadership in cardiovascular
Company Confidence:
- Despite ongoing drug price negotiations, firm commitment to growth drivers
- Confidence in achieving long-term success and $57 billion commitment by 2030
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.